There is a "possible link" between the Johnson & Johnson Covid vaccine and blood clots, according to the European Medicines Agency. The regulator says that a warning should be added to labels for the vaccine.
The Chair of the European Medicines Agency's vaccine evaluation team has said there is a connection between the AstraZeneca Covid vaccine and rare blood clots, though the exact cause of the reactions remains uncertain.
The EU's medicines agency has said that the AstraZeneca Covid vaccine is "safe and effective" to use, but a "small number of cases" of a rare clotting disorder that have occurred after vaccination cannot be ruled out.
The EU's medicines agency has responded to concerns over the Oxford-AstraZeneca Covid vaccine, saying there is "no indication" that the vaccine is the cause of reported blood clots.
